PORTOLA PHARMACEUTICALS INC - COM (PTLA)

Historical Holders from Q1 2014 to Q3 2020

Type / Class: Equity / COM
Symbol: PTLA

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2020 Q3	0	$0	-$1,334,519,741	$0	$0		0
2020 Q2	74,211,487	$1,334,611,159	+$270,845,470	$20,526,000	$5,548,000	1,799%	155
2020 Q1	77,737,863	$554,279,560	-$160,875,591	$8,122,000	$1,576,000	713%	169
2019 Q4	78,663,940	$1,878,567,201	-$19,141,845	$13,117,000	$10,738,000	2,387.98%	220
2019 Q3	79,015,808	$2,119,287,737	+$228,685,109	$10,344,000	$6,787,000	2,682%	208
2019 Q2	70,604,563	$1,914,663,149	+$15,874,395	$18,559,000	$19,368,000	2,712.98%	197
2019 Q1	69,391,690	$2,407,263,515	-$25,561,338	$14,557,000	$7,169,000	3,470%	204
2018 Q4	70,363,493	$1,372,820,626	-$75,935,025	$28,413,000	$23,873,000	1,952%	169
2018 Q3	70,670,650	$1,882,039,780	+$212,089,646	$18,762,000	$21,198,000	2,663.01%	191
2018 Q2	62,416,962	$2,357,462,705	+$205,800,934	$23,820,000	$13,681,000	3,777%	202
2018 Q1	56,997,524	$1,861,511,680	-$79,220,734	$61,160,000	$59,923,000	3,265.99%	179
2017 Q4	57,860,533	$2,816,597,337	-$10,802,861	$36,286,000	$12,424,000	4,868.01%	213
2017 Q3	57,783,027	$3,121,896,359	+$435,091,005	$32,614,000	$17,306,000	5,402.97%	221
2017 Q2	49,337,883	$2,771,375,965	+$55,054,383	$84,247,000	$85,009,000	5,616.96%	204
2017 Q1	49,078,160	$1,923,163,378	+$182,885,575	$17,943,000	$22,265,000	3,919%	177
2016 Q4	49,614,767	$1,113,355,302	-$13,745,645	$6,829,000	$11,054,000	2,244%	146
2016 Q3	50,191,810	$1,139,385,891	-$62,691,291	$6,171,000	$10,951,000	2,270.98%	148
2016 Q2	52,411,153	$1,239,578,484	-$30,086,618	$1,665,000	$3,797,000	2,360%	155
2016 Q1	53,289,601	$1,087,313,096	-$75,024,984	$14,164,000	$30,844,000	2,040%	164
2015 Q4	51,785,124	$2,664,373,408	+$133,775,505	$13,388,000	$8,158,000	5,145.01%	189
2015 Q3	49,524,368	$2,110,703,385	+$54,404,862	$8,720,000	$2,267,000	4,261.93%	170
2015 Q2	48,352,937	$2,203,063,276	+$35,047,416	$0	$2,610,000	4,554.99%	159
2015 Q1	46,630,115	$1,768,460,906	+$132,846,887	$759,000	$1,135,000	3,796%	156
2014 Q4	44,501,864	$1,260,371,765	+$210,507,991		$886,000	2,831.99%	132
2014 Q3	37,124,415	$938,524,743	+$27,532,189		$498,000	2,528%	107
2014 Q2	35,913,464	$1,047,948,698	+$80,679,718		$572,000	2,918%	109
2014 Q1	33,302,804	$862,495,333	+$72,669,056			2,589.98%	100